Quantum BioPharma Ltd.
QNTM
$3.24
-$0.20-5.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.78M | 2.21M | 2.17M | 4.04M | 4.16M |
| Depreciation & Amortization | 128.40K | 127.40K | 129.40K | 145.30K | 141.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.29M | 2.97M | 2.37M | 4.68M | 4.85M |
| Operating Income | -2.29M | -2.97M | -2.37M | -4.68M | -4.85M |
| Income Before Tax | -3.09M | -13.75M | -3.70M | -4.75M | -9.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.09M | -13.75M | -3.70M | -4.75M | -9.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -160.00K | 193.30K | 676.60K | -571.40K | 513.30K |
| Net Income | -3.25M | -13.56M | -3.03M | -5.32M | -9.25M |
| EBIT | -2.29M | -2.97M | -2.37M | -4.68M | -4.85M |
| EBITDA | -2.17M | -2.84M | -2.24M | -4.53M | -4.71M |
| EPS Basic | -0.49 | -3.02 | -0.79 | -1.40 | -3.06 |
| Normalized Basic EPS | -0.35 | -1.83 | -0.85 | -0.96 | -1.83 |
| EPS Diluted | -0.49 | -3.02 | -0.79 | -1.40 | -3.06 |
| Normalized Diluted EPS | -0.35 | -1.83 | -0.85 | -0.96 | -1.83 |
| Average Basic Shares Outstanding | 6.65M | 4.49M | 3.83M | 3.80M | 3.02M |
| Average Diluted Shares Outstanding | 6.65M | 4.49M | 3.83M | 3.80M | 3.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |